21 May 2013
Keywords: b-ms, enters, deal, worth, up, 12b, co-develop
Article | 19 January 2009
US drug major Bristol-Myers Squibb has agreed to develop a Phase Ib-stage hepatitis C drug made by US firm ZymoGenetics ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 January 2009
20 May 2013
© 2013 thepharmaletter.com